MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Not Applicable
Active, not recruiting
Conditions
Neuroblastoma
Interventions
Radiation: External beam radiotherapy
Radiation: proton beam RT
First Posted Date
2014-09-22
Last Posted Date
2024-10-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
75
Registration Number
NCT02245997
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Exercise and QUality Diet After Leukemia: The EQUAL Study

Not Applicable
Active, not recruiting
Conditions
Adult Survivors of Childhood Leukemia
Interventions
Behavioral: individual diet & physical activity counselor and website through Healthways at Hopkins
Behavioral: self directed weight loss
Behavioral: questionnaires
Other: fasting blood draw, measurement of height, weight and waist circumference, and blood pressure
First Posted Date
2014-09-19
Last Posted Date
2024-07-15
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
358
Registration Number
NCT02244411
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Not Applicable
Completed
Conditions
Pancreatic Cancer
Interventions
Drug: PEGPH20
Drug: Cetuximab
Device: DW & DCE-MRI
Other: blood draws
First Posted Date
2014-09-16
Last Posted Date
2017-09-27
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
2
Registration Number
NCT02241187
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Nintedanib in Patients With Advanced Esophagogastric Cancer

Phase 2
Completed
Conditions
Esophagogastric Adenocarcinoma
Interventions
First Posted Date
2014-09-09
Last Posted Date
2021-01-25
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
34
Registration Number
NCT02234596
Locations
🇺🇸

Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States

and more 3 locations

Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes

Phase 2
Completed
Conditions
Myelodysplastic Syndromes
Interventions
First Posted Date
2014-08-29
Last Posted Date
2022-03-09
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
25
Registration Number
NCT02228525
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Phase 2
Completed
Conditions
Advanced Colorectal Cancer
Interventions
First Posted Date
2014-08-28
Last Posted Date
2021-06-18
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
16
Registration Number
NCT02227667
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures

Phase 3
Completed
Conditions
Lung Biopsy
Interventions
Other: ABPI
Device: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug
First Posted Date
2014-08-25
Last Posted Date
2024-01-30
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
454
Registration Number
NCT02224924
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

First Posted Date
2014-08-18
Last Posted Date
2024-12-10
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
81
Registration Number
NCT02218606
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Weill Cornell Medical Center, New York, New York, United States

🇺🇸

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

and more 1 locations

IFACT: Incidental Findings in Advanced Cancer Therapy

Completed
Conditions
Bladder Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Interventions
Behavioral: Semi-structured interview
First Posted Date
2014-08-15
Last Posted Date
2023-02-13
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
60
Registration Number
NCT02217891
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Phase 1
Completed
Conditions
Rectal or Anal Cancer
Interventions
Radiation: endorectal brachytherapy
Drug: concurrent capecitabine or 5-FU
Behavioral: Questionnaires
First Posted Date
2014-07-24
Last Posted Date
2024-11-01
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
15
Registration Number
NCT02199236
Locations
🇺🇸

Memorial Sloan Kettering Commack (Consent and Follow up), Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Monmouth (Follow Up Only), Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (Follow Up Only), Basking Ridge, New Jersey, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath